v3.26.3
Financial instruments - Derivative and non-derivative financial instruments (Details)
€ in Thousands, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Aug. 31, 2025
Sep. 30, 2025
EUR (€)
Sep. 30, 2025
USD ($)
Apr. 30, 2024
item
Sep. 30, 2026
EUR (€)
Sep. 30, 2025
EUR (€)
Sep. 30, 2026
EUR (€)
Sep. 30, 2025
EUR (€)
Dec. 31, 2025
EUR (€)
Dec. 31, 2025
USD ($)
Reconciliation of derivatives embedded                    
Distributions to noncontrolling interests             € 241,464 € 505,304    
Transactions with noncontrolling interests without loss of control             (32,559) (356,527)    
Put option liabilities             (80,890) 328,407    
Income tax expense         € 77,835 € 75,225 210,417 214,528    
Reconciliation of changes in fair value measurement                    
Assets at beginning of period             31,002,333      
Assets at end of period   € 30,887,005     31,449,211 € 30,887,005 31,449,211 30,887,005 € 31,002,333  
Liabilities at beginning of period             16,719,524      
Liabilities at end of period         17,691,729   17,691,729   € 16,719,524  
InterWell Health LLC                    
Reconciliation of derivatives embedded                    
Ownership percentage 75.00%               92.00% 92.00%
Noncontrolling interests                    
Reconciliation of derivatives embedded                    
Transactions with noncontrolling interests without loss of control             (32,409) (83,692)    
Additional paid-in capital                    
Reconciliation of derivatives embedded                    
Transactions with noncontrolling interests without loss of control             (150) (272,835)    
Retained earnings                    
Reconciliation of derivatives embedded                    
Put option liabilities             (80,890) 328,407    
Shareholders of Interwell Health                    
Reconciliation of derivatives embedded                    
Settlement of put options held by non-physician investors   € 311,614 $ 363,272              
Distributions to noncontrolling interests                 € 311,614  
Increase (decrease) in put option liabilities                 (312,941)  
Income tax expense                 (34,679) $ (38,792)
Shareholders of Interwell Health | Noncontrolling interests                    
Reconciliation of derivatives embedded                    
Transactions with noncontrolling interests without loss of control                 (76,201)  
Shareholders of Interwell Health | Additional paid-in capital                    
Reconciliation of derivatives embedded                    
Transactions with noncontrolling interests without loss of control                 (235,413)  
Shareholders of Interwell Health | Retained earnings                    
Reconciliation of derivatives embedded                    
Put option liabilities                 312,941  
Maximum                    
Financial instruments                    
Term of virtual power purchase agreement       15 years            
Germany                    
Financial instruments                    
Number of wind and solar energy project developers who signed contracts with company | item       2            
United States                    
Financial instruments                    
Number of wind and solar energy project developers who signed contracts with company | item       1            
Derivatives embedded in vPPAs | Fair Value | Level 3                    
Reconciliation of derivatives embedded                    
Opening balance net assets (liabilities) January 1,             (1,733) (25,394) (25,394)  
Settlements             8,465   10,867  
Gain (loss) recognized in profit or loss             (13,900)   11,308  
Foreign currency translation and other changes             (3)   1,486  
Closing balance net assets (liabilities) June 30, and December 31,         € (7,171)   € (7,171)   € (1,733)  
Derivatives embedded in vPPAs | Fair Value | Level 3 | Expected electricity prices                    
Financial instruments                    
Increase in input         10.00%   10.00%   10.00% 10.00%
Decrease in input         10.00%   10.00%   10.00% 10.00%
Sensitivity of derivatives embedded in vPPAs to increase in input             € 22,851   € 24,356  
Sensitivity of derivatives embedded in vPPAs to decrease in input             € (22,743)   € (24,305)  
Derivatives embedded in vPPAs | Fair Value | Level 3 | Expected production volumes                    
Financial instruments                    
Increase in input         10.00%   10.00%   10.00% 10.00%
Decrease in input         10.00%   10.00%   10.00% 10.00%
Sensitivity of derivatives embedded in vPPAs to increase in input             € (717)   € 155  
Sensitivity of derivatives embedded in vPPAs to decrease in input             € 717   € (155)  
Derivatives embedded in vPPAs | Fair Value | Level 3 | Expected interest rates                    
Financial instruments                    
Increase in input         1.00%   1.00%   1.00% 1.00%
Decrease in input         1.00%   1.00%   1.00% 1.00%
Sensitivity of derivatives embedded in vPPAs to increase in input             € 335   € (183)  
Sensitivity of derivatives embedded in vPPAs to decrease in input             (384)   196  
Equity investments | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Assets at beginning of period             13,771 29,154 29,154  
Increase             4,162   2,002  
Gain / loss recognized in profit or loss             2,771   (14,487)  
Foreign currency translation and other changes             635   (2,898)  
Assets at end of period         € 21,339   21,339   13,771  
Other financial assets measured at FVPL | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Assets at beginning of period             99,154 142,264 142,264  
Increase                 7,808  
Decrease                 (22,855)  
Gain / loss recognized in profit or loss             2,584   (13,460)  
Foreign currency translation and other changes             3,493   (14,603)  
Assets at end of period         105,231   105,231   99,154  
Variable payments outstanding for acquisitions | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Liabilities at beginning of period             3,262 7,933 7,933  
Increase                 1,507  
Decrease                 (4,581)  
Gain / loss recognized in profit or loss             4,758   (928)  
Foreign currency translation and other changes             220   (669)  
Liabilities at end of period         8,240   8,240   3,262  
Put option liabilities | Fair Value | Level 3                    
Reconciliation of changes in fair value measurement                    
Liabilities at beginning of period             793,043 € 1,299,117 1,299,117  
Increase             1,585   32,307  
Decrease             (36,446)   (341,992)  
Gain / loss recognized in equity             115,751   (54,964)  
Foreign currency translation and other changes             28,485   (141,425)  
Liabilities at end of period         € 902,418   € 902,418   € 793,043  
Put option liabilities | Fair Value | Level 3 | Assumed earnings or enterprise value                    
Reconciliation of derivatives embedded                    
Increase in input, liabilities         10.00%   10.00%      
Increase (decrease) in fair value due to increase in input, liabilities             € 71,855      
Put option liabilities | Fair Value | Level 3 | Assumed earnings or enterprise value | Maximum                    
Reconciliation of derivatives embedded                    
Increase in fair value due to increase in input, as percentage of total liabilities         1.00%   1.00%      
Increase in fair value due to increase in input, as percentage of equity         1.00%   1.00%